New research in The FASEB Journal suggests that a chimera design of DNA and small DNA with a companion contrast agent to facilitate uptake allows antibodies to cross cell membranes
Scientists have identified a quantitative method to measure changes in biomarkers, which may reduce or eliminate the need for invasive biopsies. The method, described in the February 2016 issue of The FASEB Journal uses a novel chimera design of DNA and small DNA with a companion contrast agent to allow antibodies to cross cellular membranes. Once across these membranes, the tissues being evaluated can be imaged a much greater level of detail than what is possible now.
This could significantly impact the use of gene therapy and stem cell therapy, as well as lead to better diagnosis and treatment of cancer, Alzheimer’s disease, viral infections, HIV, herpes and prion diseases.
“Dr. McCoy does not have to perform a biopsy to know the disorder and cure patients without surgery in Star Trek,” said Philip K. Liu, Ph.D., a researcher involved in the work from the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital in Charlestown, Massachusetts. “This finding avoids biopsy and it makes a ‘McCoy diagnosis’ one step closer to reality.”
To make this advance, Liu and colleagues used three groups of mice. This first group received a complete chimera (antibodies to rhodopsin linked to a reporter agent and small DNA), the second group received a chimera without DNA. A third group had damaged retinas and a less rhodopsin. The first group showed a presence of the chimera in the retina using MRI (in vivo) or TEM (ex vivo). Uptake and targeting of complete chimera were compared in the third group and the first group. Results showed that the third group had significantly less uptake of chimera.
“There will be a time when biopsies are considered primitive,” said Thoru Pederson, Ph.D., Editor-in-Chief of The FASEB Journal, “and as developments in imaging technology and techniques improve our capabilities, the need for invasive, and sometimes painful, biopsies is greatly decreased.”
Learn more:Â New analysis method may reduce need for invasive biopsies
The Latest on: Invasive biopsies
[google_news title=”” keyword=”invasive biopsies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Invasive biopsies
- Monash IVF facing fresh civil suit from NSW coupleon May 20, 2024 at 10:05 am
Monash IVF are facing a fresh allegation of professional negligence relating to a genetic test meant to be less risky compared with a standard embryo biopsy.
- Scaffolding sensors detect early evidence of organ transplant rejections in miceon May 17, 2024 at 7:27 am
A new microporous scaffold functions as a minimally-invasive surveillance method to identify rejection prior to graft injury in a mouse model, according to a study published in Science Advances.
- Intense ultrasound enables less invasive cancer biopsieson May 17, 2024 at 5:12 am
Intense ultrasound helps release cancer biomarkers from cells to enable less invasive and more affordable cancer screening.
- Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsieson May 16, 2024 at 5:05 pm
The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercializat ...
- Liquid Biopsy Market to Grow at 13.1% CAGR, Revolutionizing Cancer Diagnosticson May 15, 2024 at 9:16 am
The global liquid biopsy market is projected to grow significantly, with an estimated value of USD 35.3 billion by 2033, up from USD 10.3 billion in 2023, reflecting a compound annual growth rate ...
- Skipping Axillary Lymph Node Dissection in Breast Cancer?on May 14, 2024 at 7:14 am
Axillary recurrence was rare among patients who skipped standard axillary lymph node dissection after being downstaged to node-negative disease, a recent analysis found.
- Global Cold Disposable Biopsy Forceps Industryon May 14, 2024 at 4:59 am
Global Cold Disposable Biopsy Forceps Industry is projected to grow from US$ 634.6 Mn in 2023 to US$ 1.40 Bn by 2033, at a CAGR of 8.2% ...
- Intense ultrasound extracts genetic info for less invasive cancer biopsieson May 13, 2024 at 5:46 am
Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most crucial information about a cancer, such as specific cell types and mutations, ...
- NCH Health: New tech for lung biopsies and earlier cancer detectionon May 13, 2024 at 3:03 am
In our commitment to advancing patient care, I am thrilled to introduce the latest breakthrough in lung biopsy technology.
- Global Lung Biopsy Systems Market will attain a value of USD 8.6 Billion by 2032on May 12, 2024 at 6:27 pm
The global lung biopsy systems market is poised for substantial growth, with projections estimating a market size of USD 8.6 Billion by 2032. According to a recent report by Future Market Insights ...
via Bing News